STAT3 is a key downstream signaling intermediate of gp130, a receptor previously shown to activate hematopoietic stem cell (HSC) self-renewal divisions. These findings prompted us to investigate if the STAT3 pathway is important to HSC activity in vivo. Initial semi-quantitative RT -PCR analyses showed STAT3 to be expressed at slightly higher levels in primitive subsets of both human and murine adult bone marrow cells. To test the effect of abrogating STAT3 activity in HSCs, primitive murine fetal liver cells were transduced at high efficiency with either a bicistronic dominant-negative (dn) or wild-type (wt) STAT3-IRES-GFP retrovirus. Dn STAT3-transduced HSCs showed markedly and permanently reduced in vivo lympho-myeloid reconstituting ability relative to co-transplanted non-transduced HSCs or HSCs transduced with a control (GFP-only) vector. In contrast, the activity of dn STAT3-transduced cells with short term in vivo (CFU-S) or in vitro (CFC) proliferation potential was not affected. Overexpression of wt-STAT3 had very little effect on either HSCs or shorter term progenitors. These findings suggest HSCs express non-limiting levels of STAT3 which, nevertheless, play an important stage-specific and nonredundant role in maintaining the function of HSCs stimulated to divide in adult marrow tissue.
Introduction
Blood formation is sustained throughout adult life by a small population of undifferentiated, self-maintaining hematopoietic stem cells (HSCs). These HSCs can now be detected and quantitated by sensitive and specific retrospective assays using long-term multilineage engraftment endpoints in congenic or immunodeficient mice for cells of murine (Szilvassy et al., 1990) and human Wang et al., 1997) origin, respectively. An important use of these assays has made it possible to identify many of the properties of HSCs including their responses in vitro to a variety of cytokines. Nevertheless, how self-renewal versus differentiation outcomes are determined at the molecular level in HSCs is still poorly understood. Recently, we showed that the combined activation of the flt-3 and c-kit receptors on murine HSCs is sufficient to stimulate all of these cells to divide, although the extent to which they then differentiate (or not) can be further modulated by the dose-dependent activation of gp130 (Audet et al., 2001) . This finding suggested that specific mediators of gp130 activation might modulate HSC fate decisions.
Gp130 is the signaling element used by many members of the interleukin-6 (IL-6) receptor family (Kishimoto et al., 1995) and STAT3 (signal transducer and activator of transcription 3) is a member of a family of transcription factors with important roles in initiating changes in gene expression in response to cytokine-mediated activation of various receptors, including gp130 (Darnell, 1997; Kishimoto et al., 1995; Taga and Kishimoto, 1997; Zong et al., 1998) and oncogenes. STAT3 is a 91 kd protein with a SH2 domain and is activated by phosphorylation of 2 Cterminal residues (Ser 727 and Tyr 705). Phosphorylation of Tyr 705 has been shown to cause STAT3 dimerization and its subsequent translocation to the nucleus where it can then act as a transcription factor (Zhang et al., 1995; Darnell, 1997) . Gene knock-out studies have shown that STAT3 +/7 murine embryonic stem (ES) cells have a decreased ability to be maintained in an undifferentiated state (Raz et al., 1999) and a similar result has been obtained in ES cells induced to express a dominant negative (dn) form of STAT3 (Niwa et al., 1998; Raz et al., 1999; Matsuda et al., 1999) . A second, shorter isoform of STAT3 (STAT3b) derived by alternative splicing has been described and found to inhibit the transactivation potential of STAT3(a) in a cell type-dependent manner (Schaefer et al., 1995; Caldenhoven et al., 1996; Sasse et al., 1997) . The STAT3b isoform is selectively activated in normal human CD34 + bone marrow (BM) progenitor cells and in the leukemic HL60 cell line when these are stimulated to differentiate by G-CSF (Chakraborty et al., 1996) . More recently, it has been suggested that a third and even smaller isoform (STAT3g) may exist (Chakraborty and Tweardy, 1998) .
Taken together, these findings suggest that STAT3 might have an important function in HSCs. To investigate this possibility, we first looked to see if expression of STAT3 could be demonstrated in purified subsets of adult human and murine BM cells. We then studied the effects of retrovirus-mediated overexpression of a dn form of STAT3 on the in vitro and in vivo functional activities of different early stages of differentiation of murine fetal liver cells and compared these to cells overexpressing wild-type (wt) STAT3.
Results
Increased expression of STAT3 in very primitive hematopoietic cells STAT3 transcripts were assessed in FACS-purified subsets of primitive normal adult human BM cells before and after culture for 1 -5 days using a semiquantitative RT -PCR procedure (as described in Materials and methods). Figure 1 Figure 1 ). Nevertheless, in both cases, the cytokine-induced decline in STAT3 transcript levels in CD34 + CD38 7 human BM cells appeared more rapid in the cultures that contained the two more mitogenic cytokine cocktails (containing five cytokines) (Petzer et al., 1996; Holyoake et al., 1999; Oh et al., 2000) .
Others have suggested that STAT3b can act as a dn form of STAT3 in certain cells (Caldenhoven et al., 1996) . It was therefore of interest to compare the relative levels of transcripts for both STAT3 isoforms (a and b) in primitive hematopoietic cells. As illustrated in Figure 2 , multiplex PCR analyses using isoform-specific primers showed both types of STAT3 transcripts were present in all human BM cell populations analysed (same as in Figure 1 ) and at a consistent ratio (approximately three times more a versus b transcripts).
To evaluate STAT3 protein levels in early and late hematopoietic cell types, we compared normal adult mouse BM cells, which are composed primarily of terminally differentiating cells, with the enriched population of early cells found in the BM of 5-fluorouracil (5-FU)-injected mice (Lemieux et al., 1995) . As shown in Figure 3 , the level of STAT3 protein in the more primitive hematopoietic cells was approximately twofold higher than in the predominantly mature population of cells. These findings are consistent with the transcript data for human hematopoietic cells described above. + CD38 + subpopulations were isolated from normal adult human BM and STAT3 transcript levels were either measured directly or in the progeny of the CD34 + CD38
7 cells harvested after 1 to 5 days of culture with a high or low concentration of a 5 cytokine cocktail, or TPO alone, as described in the Materials and methods. Figure 4a shows a schematic drawing of the three murine STAT3 cDNAs relevant to this study and Figure 4b shows the sequence of events thought to be triggered by ligandinduced gp130 dimerization leading to translocation of activated wt STAT3 into the nucleus. The structure of the STAT3-encoding MSCV retroviral vectors prepared are shown schematically in Figure 4c together with the probes used for detection of amplified RT products in transduced cells. Then dn STAT3 vector contained a STAT3a cDNA with a truncated Cterminus just distal to the SH2 domain (at a.a. 683). The truncated protein encoded by this dn STAT3 cDNA binds to activated gp130 and can thus serve as an antagonist of gp130-dependent endogenous STAT3 activation (see Figure 4b ). The ability of vectorencoded dn STAT3 to inhibit the phosphorylation of endogenous STAT3 was independently confirmed by Western analysis of transfected M1 cells using an antibody to tyrosine phosphorylated STAT3 (see Appendix).
Murine fetal liver cells were chosen as targets for transduction with the dn STAT3 vector in these experiments because of the high self-renewal activity of the HSC in this population . We therefore anticipated these cells to be the most sensitive to dn STAT3-mediated antagonism of HSC repopulating activity. Parallel aliquots of cells from the same suspensions were transduced with wt STAT3 or the GFP only (MIG) vector as controls. The gene transfer protocol used was based on previous observations that fetal liver HSC activity is difficult to maintain in vitro, even when the cells are incubated in the presence of a combination of cytokines that supports a net expansion of adult mouse BM HSCs . Preliminary experiments showed that 2 days of cytokine stimulation of TER119 7 (HSC-enriched) fetal liver cells followed by a single exposure to the MIG virus for 16 h was sufficient to obtain 70% GFP + cells 2 days later. Subsequent experiments using all three vectors gave similar results ( Figure 5a , Table 1 ). Western analysis using an anti-STAT3 antibody confirmed the expression of both wt and dn STAT3 proteins of the expected sizes in the fetal liver cells transduced with the wt and dn STAT3 vectors, respectively ( Figure 6 ).
CFU-S and CFC assays performed immediately post-infection (on unselected cells) showed no differences (P40.05) in the number or appearance of spleen colonies or colonies obtained in vitro from either the wt or dn STAT3-transduced cells in comparison to the MIG-transduced (control) fetal liver cells ( Figure 7 ). The frequencies of both of these classes of progenitors in all groups also remained similar to the frequencies of these cells in the original cell population. Similar results were obtained in a further experiment in which the GFP + cells were FACS-sorted at the end of the transduction protocol and then assayed for their CFU-S content (4.4+1.2, 2.8+0.4 and 3.5+0.5 for MIG, dn STAT3 and wt STAT3-transduced CFU-S per 10 4 GFP + cells, respectively). A different picture was seen when the peripheral blood of mice transplanted with dn STAT3-transduced cells was assessed over a more prolonged period to assess effects on HSC activity. Figure 5b compares the FACS profiles obtained on blood samples from representative mice in each of the three groups. Figure 8 shows for each mouse transplanted, the proportion of WBCs that were derived from both transduced (GFP + ) and nontransduced (GFP 7 ) fetal liver cells. The fact that the suppression of WBC production by dn STAT3-transduced cells did not extend to the non-transduced (GFP 7 ) repopulating cells co-transplanted into the same recipients indicates that the dn STAT3 effect was specific and not explicable by some toxicity in that virus preparation. Interestingly, in spite of the suppressive effect of dn STAT3 seen on the overall production of WBCs, the proportion of lymphoid and myeloid elements within the GFP + fraction of the WBCs in all mice was normal (Table 1 ). This suggests that expression of dn STAT3 did not affect HSC commitment.
In contrast to the results seen in the recipients of dn STAT3-transduced cells, there was no difference in the levels of GFP + WBCs generated from wt STAT3-transduced cells as compared to MIG-transduced cells after 5 weeks (Table 1 and Figure 5b ).
To determine whether the small numbers of GFP + WBCs produced in the mice transplanted with dn STAT3-transduced cells were expressing the dn STAT3 gene, RT -PCR analyses were performed on WBC lysates using vector-specific primers and probes ( Figure  4c ). As shown in Figure 9 , vector-derived GFP and STAT3 transcript sequences were seen in the WBCs of all 5 week-engrafted mice from the groups that received either wt or dn STAT3 vector-transduced cells, whereas only GFP transcript sequences were found in the WBCs of recipients of MIG-transduced cells. The picture seen at 5 weeks post-transplant persisted in most mice for up to a year, although the absolute levels of engraftment in all groups decreased and some evidence of a late dn effect in the recipients of wt STAT3-transduced cells was seen (Figure 8 ). However, in two of the 12 recipients of dn STAT3-transduced fetal liver cells, significant numbers (*30%) of GFP + lymphoid and myeloid cells had appeared by 14 weeks post-transplant. By 1 year post-transplant, these populations had increased even further, although the ratio of GFP + lymphoid to myeloid WBCs in both these mice did not change. Diagnostic RT -PCR analyses showed the presence of dn STAT3 transcripts in the WBCs of both without evidence of anomalies (data not shown). Analysis of the sites of transgene integration in spleen colonies obtained in secondary recipients of FACS-selected GFP + BM cells isolated from the primary mice 1 year post-transplant (Fraser et al., 1992) indicated that in each of these primary mice, the GFP + CFU-S belonged to a single clone (data not shown). This strongly suggests that the increased proportion of GFP + WBCs present by 14 weeks in each of these two mice resulted from the expansion of a single dn STAT3-transduced HSC. However, from the data available the possibility of small mutations in the dn STAT3 transgene that might have affected its function could not be ruled out. Alternatively, mechanisms overriding the usual effects of dn STAT3 due to a specific site of insertion may have been operative.
Discussion
In the last few years it has been determined that HSCs must be stimulated by multiple specific cytokines in order to be maintained in a viable, proliferating and self-renewing state in vitro. In addition, it is now clear that the possibility a HSC will execute a self-renewal division (versus a division in which its daughter cells have lost the defining properties of an HSC) can vary according to the particular cytokine conditions under + human BM population and the most mature (CD34 7 ) cells were compared (Chakraborty et al., 1996; Biethahn et al., 1999) . Higher levels of STAT3 protein were also seen in murine BM cells depleted of more mature cells by 5-FU treatment. Figure 4(c) ). The resultant ethidium bromide-stained products are shown in the top panel and the GFP-probed Southern blots of the same gels are shown in the middle. Results for b-actin are shown in the bottom panel. Each lane shows the results for a single mouse whose per cent GFP + WBCs is indicated in brackets. Lanes labeled MIG/ DNA, dnS/DNA and WT/DNA were loaded with PCR products from plasmids containing the MIG, dn STAT3 and wt STAT3 vectors as positive controls. Also included as positive controls were RT -PCR products from RNA extracts of the corresponding GPE-86 producer cells (MIG, GPE-dnS and GPE-WT) A gene transfer strategy was then used to determine whether HSC behavior would be influenced either by overexpression of normal STAT3, or suppression of the activity of endogenous STAT3 by overexpression of a dn form of STAT3. The striking and reproducible result from the latter experiments was a dramatic and selective failure of fetal liver cells transduced with the dn STAT3 to regenerate detectable numbers of lymphoid or myeloid progeny in transplanted congenic recipients when these were followed from 5 weeks to 1 year later. Several findings argue strongly that this result was not due either to a non-specific toxic effect of the dn STAT3 virus preparation nor to a failure to transduce fetal liver HSCs. First, HSCs exposed to, but not transduced by the dn STAT3-GFP vector reconstituted recipient mice as effectively as non-transduced HSCs from similarly unselected populations of cells exposed to the control vector (encoding GFP only). Second, all three viral preparations were of a similarly high titer and gave correspondingly high levels of GFP + cells immediately after infection of the HSCenriched populations used. Expression of both wt and dn STAT3 protein in these infected fetal liver cells was confirmed and transcripts from an intact dn STAT3 transgene were demonstrable in the small numbers of WBCs regenerated in vivo in every recipient of dn STAT3-transduced cells examined. Third, recipients of aliquots of the same transduced cells sacrificed 12 days post-transplant showed no evidence of an ability of dn STAT3 to impair the in vivo proliferation or differentiation of hematopoietic cells that had reached the day 12 CFU-S stage and a similar lack of effect of dn STAT3 was seen in CFC assays of cells infected with this vector. In preliminary experiments using adult mouse BM cells as targets for transduction, we have seen the same differential pattern of effects of dn STAT3 on HSCs (inhibition) and CFU-S (no effect, unpublished findings). Taken together, these observations indicate that the reduced repopulating activity exhibited by dn STAT3-transduced HSCs is most likely due to a specific perturbation of the self-renewal mechanism that is critical to their life-long hematopoietic activity and is no longer operative at the level of CFU-S or later stages of hematopoietic cell differentiation.
Interestingly, we found that overexpression of wt STAT3 in hematopoietic cells had no apparent enhancing effect on them at any stage of differentiation, either in vitro or in vivo. This included a lack of effect on the lympho-myeloid repopulating activity of HSCs for the first 14 weeks post-transplant, during which we have now shown some level of STAT3 function appears to be essential. The slightly inhibitory effect of wt STAT3 overexpression seen after 1 year is consistent with previous observations of this outcome in the M1 cell line (Minami et al., 1996) . We also showed that the highest levels of endogenous STAT3 were present in the most primitive hematopoietic cell types. Thus, STAT3 may be a requisite but not limiting regulator of HSC amplification.
Previous experiments have identified cytokines that utilize gp130 as a common signaling element to be important for HSC generation in vivo (Bernad et al., 1994) and mice lacking gp130 show reduced numbers of fetal liver CFU-S (Yoshida et al., 1996) . The present studies suggest that this is likely due to a requisite role of gp130 for their generation rather than for their detection. Interestingly, mice transgenic for IL-6 and IL-6 a-receptor production in the liver show increased hematopoiesis in this organ (Peters et al., 1997) ; however, the cell type(s) in which these effects are initiated have not yet been defined. In addition, although many genes whose expression can be altered by STAT3 have been identified, those that might be relevant to the regulation of HSC fate decisions have yet to be determined. Our data predict that these may include genes whose products maintain lineage options, perhaps by regulating the kinetics or sequence of molecular changes during passage through G 1 (Cheng et al., 2000) . Previous studies have also shown that maintenance of the totipotent properties of ES cells similarly depends on gp130-activated STAT3 signaling (Raz et al., 1999; Niwa et al., 1998; Matsuda et al., 1999) . Thus a broader role of this pathway in maintaining the stem cell state of stem cells in other tissues may be anticipated.
Materials and methods

Mice
These were generated in the animal facility of the British Columbia Cancer Research Center from breeders originally obtained from the Jackson Laboratories (Bar Harbor, ME, USA) and were housed in microisolator cages and provided with sterilized food and acidified water. Recipients in transplantation experiments were 8 -12-week-old C57BL/6J-W 41 /W 41 -Ly5.2 (W 41 ) mice. Liver cells were obtained from C57B1/6J-Pep 3b-Ly5.1 (Pep 3b) fetuses removed after 14.5 days of gestation. BM cells were from normal adult Balb/cJ mice or adult Balb/cJ mice that had been injected intravenously 4 days previously with 150 mg/kg 5-FU (Faulding, Vaudreuil, Quebec, Canada).
Human cells
Normal adult human BM cells were obtained either from the Northwest Tissue Center (Seattle, WA, USA) or were leftovers from allogeneic transplants obtained in our center with informed consent according to institutional guidelines. Low-density (51.077 gm/cm 3 ) cells were isolated by centrifugation on ficoll-hypaque (Pharmacia, Baie D'Urfe, Quebec, Canada) and then cryopreserved at 71358C until required.
Cell purification
Single cell suspensions of murine fetal liver were obtained by pushing the tissue through a nylon sieve. The cells were then washed twice in Hank's balanced salt solution containing 2% fetal calf serum (HF2, StemCell Technologies, Vancouver, BC, Canada) and a progenitor-enriched (*10-fold) suspension obtained by immunomagnetic removal of TER119 + cells (using a StemSep TM column from StemCell) (Thomas et al., 1999) .
Highly purified populations of CD34 + CD38 7 and CD34 + CD38 + human BM cells were isolated by FACS as previously described (Oh et al., 2000) using a 2 laser FACStar Plus (Becton Dickinson, San Jose, CA, USA) from thawed samples of low density human BM cells after removal of those expressing CD2, CD3, CD14, CD16, CD19, CD24, CD56, CD66b and glycophorin A on a StemSep TM column (Thomas et al., 1999) . Viable (propidium iodide (PI, Sigma Chemicals, St. Louis, MO, USA)-negative) CD34 + cells with low to medium forward light scattering characteristics were subdivided into CD38 7 and CD38 + subsets using gates that excluded 99% of cells stained with matched isotype control antibodies labeled with the same fluorochrome. Cells of the desired phenotype were then collected into Iscove's medium (IMDM, StemCell) containing a serum substitute (BIT TM (StemCell) plus 10 74 M 2-mercaptoethanol (2-ME) and 40 mg/ml low-density lipoproteins (LDL, Sigma)).
Cultures
M1 cells (Minami et al., 1996) were maintained in IMDM plus 10% fetal calf serum (FCS, StemCell). Human CD34 + CD38 7 BM cells were cultured as previously described (Petzer et al., 1996) in serum-free medium with the following cytokine combinations: either 300 or 10 ng/ml FL (Immunex Corp, Seattle, WA, USA) plus 300 or 10 ng/ml SF (Amgen, Thousand Oaks, CA, USA) plus 60 or 2 ng/ml IL-3 (Novartis, Basel, Switzerland) plus 60 or 2 ng/ml IL-6 (Cangene, Mississauga, Ontario, Canada) plus 60 or 2 ng/ml granulocyte-colony stimulating factor (G-CSF, StemCell) (Zandstra et al., 1997) (referred to as the 'high' and 'low' concentration cocktails, respectively), or 50 ng/ml thrombopoietin (TPO, Genentech, San Francisco, CA, USA) alone.
RNA extraction and reverse transcriptase -PCR (RT -PCR) analyses
These procedures were performed on human BM cells as previously described (Oh et al., 2000) . Briefly, RNA was extracted from aliquots of at least 5610 3 cells using glycogen as a carrier and reverse transcription performed using a 60-mer oligo (dT) primer followed by a tailing reaction using terminal deoxynucleotidyl transferase (GIBCO/BRL, Grand Island, NY, USA). Aliquots from this reaction were then PCR-amplified initially for 25 cycles and then a tenth of the reaction mixture was amplified for 25 more cycles with addition of fresh Taq polymerase (GIBCO/BRL). For the multiplex RT -PCR analyses of STAT isoform expression, aliquots of the cDNAs obtained from the reverse transcription reaction were amplified using the following primers (5'-TCC TGA CAT TCC CAA-3' and 5'-AGC TTC CGT TCT CAG C-3') as described (Caldenhoven et al., 1996) . Primers for b-actin (5'-GTG CGT GAC ATT AAG GAG AA-3' and 5'-GGA GGG GCC GGA CTC GTC A-3') were added as an internal control of the amplification reaction (in the presence of 60 mM KCl, 120 mM Tris-HCl, 2.5 mM MgCl 2 ). PCR products were electrophoresed in agarose and stained with ethidium bromide for quantification using a Kodak Digital Science ID TM scanner and image analysis software (Eastman Kodak Company, Rochester, NY, USA).
For RT -PCR analyses of murine cells, RNA was purified from blood leukocytes (obtained by NH 4 Cl lysis of the RBC) using Ultraspec (Biotecx, Houston, TX, USA) according to the manufacturer's protocol. CDNAs were synthesized using random hexamers and Superscript (GIBCO/BRL) and then the following primers used for the PCR: 5'-CTT GAA CCT CCT CGT TCG-3' (MSCV 5'), 5'-GGT AGC GGC TGA AGC ACT GCAC-3' (GFP-3'), 5'-CGA GAC TCT TCC CAC AGG-3' (STAT3 3'), 5'-AGA TCA TGG ATG CGA CC 3' (STAT 3 5'). MSCV-IRES-GFP (MIG) transcripts were detected using the MSCV 5' plus the GFP 3' primers. Transduced STAT3 transcripts were detected using either the MSCV 5' plus the STAT3 3' primers or the STAT3 5' plus the GFP 3' primers since both combinations allowed their distinction from endogenous STAT3.
Southern analyses
Amplified cDNAs were electrophoresed in agarose gels and transferred to nylon membranes (Hybond-N, Amersham, Buckinghamshire, UK) for hybridization with human and murine STAT3 cDNA and GFP probes obtained as follows. The a-specific cDNA of human STAT3 obtained from the multiplex RT -PCR described above was first subcloned into a TA cloning vector (Invitrogen, San Diego, CA, USA) to allow verification of the insert sequence by automated DNA sequencing. The insert was then released by EcoRI digestion and used as a probe for human STAT3. A cDNA probe for murine STAT3 was obtained by EcoRI/XhoI digestion of the MSCV-STAT3 vector to release the full-length STAT3 cDNA. A GFP cDNA probe was obtained by EcoRI/NotI digestion of the pEGFP-N1 plasmid (Clontech, Palo Alto, CA, USA) to release the full-length EGFP cDNA. Probes were labeled with 32 P using a random primer kit (GIBCO/ BRL) and blots hybridized for 12 -16 h at 458C in 40% formamide, 50 mM NaPO 4 , 0.5% SDS, 56SSPE, 56Denhardt's solution, 0.25 mg/ml denatured salmon sperm DNA and 10 mg/ml sodium dextran, followed by washing first in 26SSC plus 0.1% SDS at room temperature and then in 0.26SSC plus 0.1% SDS once at 508C and finally at 558C.
For Southern analyses of virus-producing GP+E-86 clones, genomic DNA was isolated using DNAzol (GIBCO/BRL) and then digested overnight with Sst1 before electrophoresis, Southern blotting onto Hybond-N filters and hybridization with the GFP probe. Hybridization was visualized either by exposure of the filters to a phosphorimager screen (Molecular Dynamics, Sunnyvale, CA, USA) for 2 -4 h or to an X-ray film for 1 -2 days and the signals scanned in a phosphorimager (Storm 860, Molecular Dynamics) and quantified using Molecular Dynamics APPS software, except in the case of gene-specific primer-mediated RT -PCR analyses. For these, the filters were autoradiographed using a 10 -30 min exposure and the signals were quantified using the Personal Densitometer SI (Molecular Dynamics) and the APSS software. Where transcript levels were assessed, these were calculated by first subtracting any background obtained in the RT control simultaneously hybridized to the same filter and then normalized according to the level of GAPDH transcript detected upon stripping the filter and re-probing it with a GAPDH probe as described previously (Oh et al., 2000) . For comparisons of transcript levels between different subpopulations, the normalized values were expressed as a ratio relative to the reference population assessed on the same gel and filter.
Preparation of retroviral vectors and infectious virus
A MSCV -IRES -GFP vector generated by introduction of an internal ribosomal entry site (IRES) cassette and a downstream enhanced GFP cDNA into the MSCV vector backbone originally produced by Dr R Hawley (American Red Cross, Rockville, MD, USA) was obtained from Dr K Humphries (Terry Fox Laboratory, Vancouver, BC, Canada). The wt murine STAT3 cDNA was obtained by replacing the gyrase-encoding sequences of the STAT -Gyr fusion gene (obtained from Dr A Mui, Jack Bell Research Center, Vancouver Hospital, Vancouver, BC, Canada) with phosphorylated oligonucleotides containing Mlu1 and Not1 sites and an in frame stop codon. These were prepared by hybridizing sense (5'-CGC GTT GAGC-3') and antisense (5'-GGC CGC TCAA-3') oligonucleotides followed by their phosphorylation using polynucleotide kinase (GIBCO/BRL). The resultant wt STAT3 cDNA was released from pME18S by digestion with EcoR1/Not1 and inserted into the EcoR1/ Not1 site of the MIG plasmid. The murine dn STAT3 cDNA was released from the pBabe/puro D STAT3 plasmid, also obtained from Dr A Mui (O'Farrell et al., 1998) , by EcoR1/ Not1 digestion. After blunting the Not1 site, the released dn STAT3 insert was then subcloned into the EcoR1 and blunted Xho1 sites of the MIG vector. All vectors were sequence verified using an automated DNA sequencer.
To obtain infectious retrovirus, each construct was transfected into Phoenix-ecotropic packaging cells and 48 h supernatants then used to infect GP+E-86 cells (Markowitz et al., 1988) on three consecutive days. Two days after the last infection of the GP+E-86 cells, the latter were cloned and those producing the highest titer virus (as determined by transfer of GFP expression to NIH3T3 cells, 5 -10610 6 IU/ ml) and containing intact proviral integrants as shown by Southern analyses were then selected. Stably transduced IL-6-responsive M1 leukemic cells were shown to express STAT3 proteins of the expected size by Western analysis and the ability of the dn STAT3 expressed in these cells to inhibit IL-6-activated phosphorylation of endogenous STAT3a was also demonstrated using an antibody specific for tyrosine phosphorylated STAT3 (data not shown).
Gene transfer
Primary murine TER119
7 fetal liver cells were first incubated for 48 h (in the absence of virus) in serum-free medium (IMDM+BIT TM +10 74 M 2-ME+40 mg/ml LDL) plus 50 ng/ml murine SF (purified in the Terry Fox Laboratory from the supernatants of murine SF cDNA-transfected COS cells), 100 ng/ml human FL and 100 ng/ml human IL-11 (Genetics Institute, Cambridge, MA, USA). The cells were then centrifuged, resuspended in virus-containing supernatant plus 5 mg/ml protamine sulfate and transferred to tissue culture dishes that had been preloaded with virus as previously described (Hennemann et al., 2000) . After a 16 h incubation with virus, the cells were harvested (taking care to collect any adherent cells using a sterile scraper) and were then washed with HF2 and injected directly into W 41 mice or plated in methylcellulose with additional aliquots being maintained for 48 h in DMEM+10% FCS plus the same cytokines as present during the infection period for measurements of gene transfer efficiency (per cent GFP + cells). In one experiment, the GFP + cells were sorted by FACS and then assayed for CFU-S (as described below).
Western analyses
Cells were lysed in 26 Laemmli buffer and the lysate electrophoresed in 10% polyacrylamide gels, then transferred to PVDF membranes (Millipore, Bedford, MA, USA). For detection of wt or dn STAT3, each membrane was blocked with TTS solution (25 mM Tris, pH 7.4, 0.05% Tween 20, 150 mM NaCl) containing 3% skim milk before being incubated with a polyclonal rabbit anti-mouse STAT3 antibody (K15, Santa Cruz Biotech, Santa Cruz, CA, USA) for 1 h. The membrane was then washed three times in TTS solution and incubated with a secondary anti-rat Ig conjugated with horse radish peroxidase (Upstate Biotechnology, Lake Placid, NY, USA), washed again three times and developed using a chemiluminescence developing kit (Amersham Pharmacia Biotech). For detection of phosphorylated STAT3, the same general procedure was followed except that the blocking solution contained 5% milk and the primary antibody was a phosphotyrosine-specific anti-STAT3 antibody (Upstate Biotechnology) and it was incubated with the filter for 4 h at 48C.
Assays of primary hematopoietic progenitor activity
For in vivo colony-forming unit-spleen (CFU-S) assays as well as for assays of longer term repopulating activity (up to 1 year), W 41 -Ly5.2 mice were given a sublethal dose of 400 cGy 137 Cs g-rays and then were injected intravenously with the test (+/+-Ly5.1) cells. CFU-S numbers were determined by counting the number of macroscopically visible colonies on the surface of spleens removed 12 days post-transplant and fixed in 63% ethanol, 5% glacial acetic acid and 5% formaldehyde. After 12 days the spleens of mice given no cells under these conditions contained no colonies. For assessment of long-term lympho-myeloid repopulating activity, recipient mice were bled from the tail vein and, after lysis of the RBCs, the WBCs were washed twice in HF2 and resuspended in HF2-containing 5% rat serum. Separate aliquots were then stained with anti-Gr-1 and anti-Mac-1 antibodies and counter-stained with anti-Ly5.1 antibody to assess myeloid engraftment, and with anti-B220 and anti-TB104 antibodies to assess lymphoid engraftment as described (Szilvassy et al., 2001) . The cells were then analysed in a FACSCaliber TM (Becton Dickinson). In vitro assays of myeloid colony-forming cell (CFC) activity (including the formation of erythroid, granulopoietic and multi-lineage colonies) were performed by plating appropriate aliquots of cells in methylcellulose medium (Methocult 3434, StemCell) and counting the various types of colonies present after 12 days of incubation at 378C using standard scoring criteria.
